NCT03009058 2024-11-25
MODULATE
Immodulon Therapeutics Ltd
Phase 1/2 Terminated
Immodulon Therapeutics Ltd
H. Lee Moffitt Cancer Center and Research Institute
The Cleveland Clinic
VA Office of Research and Development
Massachusetts Eye and Ear Infirmary
Actavis Inc.
Wake Forest University Health Sciences